An alarming high prevalence of resistance-associated mutations to macrolides and fluoroquinolones in Mycoplasma genitalium in Belgium: results from samples collected between 2015 and 2018.
De Baetselier IrithChris Richard KenyonWim Vanden BergheHilde SmetKristien WoutersDorien Van den BosscheBea VuylstekeTania CrucittiPublished in: Sexually transmitted infections (2020)
The study shows an alarmingly high prevalence of MG with RAMs to macrolides and fluoroquinolones in Belgium. These results highlight the need to improve antimicrobial stewardship in Belgium in order to avoid the emergence of untreatable MG.
Keyphrases